首页> 外国专利> (2S, 3R, 4R, 5S, 6R) - 2 - (2, 3-dihydro-1h-inden-5-il or 2, 3-dihydrobenzofurano-5-il) - 6 - (hydroximetyl) - tetrahydro-2h-piran-3, 4, 5-trial, sodium glucose conjugated carrier inhibitor (SGLT) in intestine and kidney; It is used to treat diabetes, diabetic complications, obesity and other diseases caused by hyperglycemia.

(2S, 3R, 4R, 5S, 6R) - 2 - (2, 3-dihydro-1h-inden-5-il or 2, 3-dihydrobenzofurano-5-il) - 6 - (hydroximetyl) - tetrahydro-2h-piran-3, 4, 5-trial, sodium glucose conjugated carrier inhibitor (SGLT) in intestine and kidney; It is used to treat diabetes, diabetic complications, obesity and other diseases caused by hyperglycemia.

机译:(2S,3R,4R,5S,6R)-2-(2,3-二氢-1h-茚基-5-il或2,3-二氢苯并呋喃基-5-il)-6-(氢氧嘧啶)-四氢-2h- piran-3,4,5-trial,钠葡萄糖缀合的载体抑制剂(SGLT)在肠和肾中;它用于治疗糖尿病,糖尿病并发症,肥胖症和高血糖症引起的其他疾病。

摘要

p This Invention Bertalanffy refers to a New derivative BIC & iacute; CLICO has an Inhibitory activity against Sodium - linked glucose Transporters (SGLT) present in the intestines and the Ri & ntilde; ones, or Salt, is & amp; Grouper, hydrate or solvate & pharmaceutical the uticamente aceptab Are the same,And a Pharmaceutical composition & acute; S & eacute; utica comprising the same as an active ingredient, which effectively inhibit the activity of SGLT, and therefore can be used as a Therapeutic Agent & eacute; products for the treatment of diseases caused p / p
机译:本发明Bertalanffy是指新的衍生物BIC&iacute; CLICO对肠和Ri&ntilde中存在的钠连接的葡萄糖转运蛋白(SGLT)具有抑制作用。或盐,是&amp;石斑鱼,水合物或溶剂化物与药学上常用的成分相同,且药物成分为急性; S&eacute;含有与有效成分相同的有效成分,可有效抑制SGLT的活性,因此可用作治疗剂。用于治疗引起疾病的产品p < / p>

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号